Economics

This channel highlights factors that impact hospital and healthcare economics and revenue. This includes news on healthcare policies, reimbursement, marketing, business plans, mergers and acquisitions, supply chain, salaries, staffing, and the implementation of a cost-effective environment for patients and providers.

Thumbnail

Subsidies on healthy eats, taxes on sugary drinks may lead to better cardiovascular outcomes

A microsimulation cardiovascular disease risk prediction model found that a 10 percent subsidy on the price of fruits and vegetables would lead to reductions in cardiovascular disease deaths, non-fatal MI and non-fatal stroke. 

Thumbnail

Lawsuit alleges Johnson & Johnson, Bayer misled New England Journal of Medicine editors

Lawyers for patients suing Johnson & Johnson and Bayer allege that the companies misled editors at The New England Journal of Medicine about the safety of rivaroxaban (Xarelto), the New York Times reports. 

Thumbnail

Medtronic’s revenue increases in Q3 but shares fall after earnings release

During the third quarter of fiscal year 2016, Medtronic’s revenue increased six percent to $6.394 billion, while its diluted earnings per share decreased one percent to $0.77 per share.

Medtronic increases cash dividend 25 percent for fiscal year’s fourth quarter

For the fourth quarter of fiscal year 2016, Medtronic will increase its cash dividend by 25 percent to $0.38 per ordinary share, the company announced on Feb. 19.

Stryker agrees to acquire Physio-Control for $1.28 billion

Stryker Corporation agreed to buy Physio-Control International on Feb. 16 for $1.28 billion in an all-cash deal.

HIMSS reports on 2016’s ‘growth technologies’

Healthcare Information and Management Systems Society (HIMSS) Analytics has published a report on some of the technologies shaping hospitals’ purchase plans in 2016.

Edwards Lifesciences agrees to repurchase $325 million of its common stock

Edwards Lifesciences announced on Feb. 4 that it had agreed to repurchase $325 million of its common stock from Morgan Stanley & Co. Edwards is funding the accelerated share repurchase using available cash, according to a news release.

Thumbnail

Boston Scientific’s revenue and earnings per share increase in Q4

For the fourth quarter of 2015, Boston Scientific’s sales hit $1.978 billion, representing a 10 percent jump in operational revenue compared with the same time period the previous year, while its adjusted earnings per share increased from $0.22 to $0.26.

Around the web

Several key trends were evident at the Radiological Society of North America 2024 meeting, including new CT and MR technology and evolving adoption of artificial intelligence.

Ron Blankstein, MD, professor of radiology, Harvard Medical School, explains the use of artificial intelligence to detect heart disease in non-cardiac CT exams.